touchPODCAST

touchFOCUS for touchONCOLOGY

Listen to Dr Balazs Halmos answer a series of questions focused on the distinctive clinical features of squamous cell lung cancer, the challenges they pose to developing a treatment plan, and the role immunotherapy plays in overcoming them. 

The expert:

• Dr Balazs Halmos - Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Regeneron. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchoncology.com/

touchFOCUS for touchRESPIRATORY

Listen to Dr Balazs Halmos answer a series of questions focused on the distinctive clinical features of squamous cell lung cancer, the challenges they pose to developing a treatment plan, and the role immunotherapy plays in overcoming them. 

The expert:

• Dr Balazs Halmos - Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Regeneron. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchrespiratoryime.org/

touchIN CONVERSATION for touchONCOLOGY

Listen to Dr Nilanjan Ghosh in conversation with Dr Peter Riedell. They respond to questions submitted by the HCP audience and provide their expert insights regarding new horizons in relapsed or refractory follicular lymphoma, with a focus on risk stratification and managing the practicalities of CAR T-cell therapy.

This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical educational grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.

For further information visit our website: touchoncology.com/ 

touchIN CONVERSATION for touchHAEMATOLOGY

Listen to Dr Nilanjan Ghosh in conversation with Dr Peter Riedell. They respond to questions submitted by the HCP audience and provide their expert insights regarding new horizons in relapsed or refractory follicular lymphoma, with a focus on risk stratification and managing the practicalities of CAR T-cell therapy.

This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME. 

touchFOCUS for touchOPHTHALMOLOGY

Listen to Dr John Hovanesian answer a series of questions focused on how to effectively manage patients prior to cataract surgery and ensure the most appropriate intraocular lens (IOL) formula is used, including his views on recent advances in IOL technology. 

The expert:

• Dr John Hovanesian, University of California, Los Angeles, Jules Stein Eye Institute, CA, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Alcon Vision, LLC,. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchophthalmologyime.org/advances-in-iol-technology-and-power-calculations-updates-and-innovations/

touchEXPERT OPINIONS for touchONCOLOGY

 Two oncologists summarize the latest US and European guidelines for the treatment of recurrent/metastatic cervical cancer and a nurse practitioner considers key safety considerations for immunotherapy and targeted treatments.

The experts

• Dr David O’Malley - James Comprehensive Cancer Center, Columbus, OH, USA

This touchPODCAST is for HCPs only.

 This activity is funded by an independent medical educational grant from Merck and Co., Inc and Seagen Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchoncologyime.org/guideline-management-recurrent-metastatic-cervical-cancer 

touchSATELLITE SYMPOSIUM for touchIMMUNOLOGY

Listen to this touchSATELLITE SYMPOSIUM recorded live in November at the ACR Convergence 2023, in San Diego, CA, USA. 

Prof. John Stone (USA), the chair for the symposium, is joined by Dr Emanuel Della Torre (Italy) and Dr Arezou Khosroshahi (USA). 

The first session, led by Prof. John Stone (02:27), focuses on the pathophysiology and varying clinical presentations of IgG4-related disease (IgG4-RD). This is followed by an audience Q&A (13:11).

The second session, led by Dr Emanuel Della Torre (15:43), reviews the classification criteria for IgG4-RD and how to diagnose the condition. This is followed by an audience Q&A (25:22).

In the third session, Dr Arezou Khosroshahi (29:53) looks at how to treat IgG4-RD and discusses the optimal use of glucocorticoids to induce and maintain remission, and summarizes the targeted treatments for IgG4-RD that are in clinical development. This is followed by an audience Q&A (39:51). 

The symposium concludes with a panel discussion and a case presentation (44:06). 

This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchimmunologyime.org/igg4-related-disease-identify-diagnose-treat/

touchPANEL DISCUSSION for touchIMMUNOLOGY

Listen to a panel of experts as they discuss the burden of atopic dermatitis in children and their families, when treatment escalation with systemic therapy should be considered, and how to support patients and their families to achieve long-term control of symptoms.

The experts

• Dr Elaine Siegfried - Cardinal Glennon Children’s Hospital, St. Louis, MO, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchimmunologyime.org

touchPANEL DISCUSSION for touchDERMATOLOGY

Listen to a panel of experts as they discuss the burden of atopic dermatitis in children and their families, when treatment escalation with systemic therapy should be considered, and how to support patients and their families to achieve long-term control of symptoms.

The experts

• Dr Elaine Siegfried - Cardinal Glennon Children’s Hospital, St. Louis, MO, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchdermaime.org

touchEXPERT OPINIONS for touchNEUROLOGY

A leading multiple sclerosis (MS) specialist shares key considerations for a personalized treatment strategy for patients with relapsing forms of MS, and goes on to explore the key role that B cells play in the pathogenesis and progression of MS, including the therapeutic potential of B-cell–targeted agents.

The expert

• Prof. Martin Weber, University Medical Center Göttingen, Germany

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Sanofi. This activity is jointly provided by USF Health and touchIME. 

For further information visit: touchneurologyime.org/eo-update-on-optimizing-management-of-rms